Wednesday, May 24, 2017

Pharmacogenetic Testing and the Treatment of Pain

 

Personalized medicine is on the forefront of medicine. By utilizing genetic testing we may be able to predict patient response and avoid potential medication failures. In the video below, Anita Gupta, MD, shares a real patient story about how pharmacogenetic testing helped a patient with severe chronic pain:

She also explained what physicians need to know about phamacogenetic testing, how to interpret results and how to apply them to patient care:

Want to learn more about pharmacogenetic testing? Take our 1-hour CME activity, which are always free to our members and only $25 for non-members. Upon completion of this activity, participants should be better able to:

  1. Identify the areas of current and future potential applications of pharmacogenomics to tailor medication therapy in the treatment of pain.
  2. Describe the impact of the following drug metabolizing phenotypes extensive metabolizer, intermediate metabolizer, poor metabolizer, and ultra-rapid metabolizer on medication efficacy and toxicity for both regular substrates and prodrugs.
  3. Apply pharmacogenomics test results in a patient case with pain diagnosis to recommend appropriate doses for affected medications.
  4. Predict the impact of a CYP450 inhibitor and inducer on metabolic capability of each metabolizing phenotype for both regular and prodrug substrates.

Learn more about this course and others in our Pain Care Learning Center.

Leave a Reply

Your email address will not be published. Required fields are marked *

More Pharmacogenetic Testing Stories

About The Academy

The American Academy of Pain Management improves the lives of people with Pain by advancing a person-centered, integrative model of pain care through evidence-guided education, credentialing, and advocacy.